Spots Global Cancer Trial Database for conditioning
Every month we try and update this database with for conditioning cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Fludarabine/Busulfan and Cyclophosphamide Conditioning for Adult Lymphoid Malignancies | NCT01435447 | Lymphoid Malign... | FLu-Bu-Cy | 16 Years - 60 Years | Shanghai Jiao Tong University School of Medicine | |
| Decitabine + BUCY vs BUCY Conditioning Regimen for Myeloid Tumors Undergoing Allo-HSCT | NCT04098653 | Allogeneic Hema... Conditioning Myeloid Tumors | Decitabine Busulfan (BU) Cyclophosphamid... | 14 Years - 65 Years | Nanfang Hospital, Southern Medical University | |
| Decitabine + BUCY vs BUCY Conditioning Regimen for Myeloid Tumors Undergoing Allo-HSCT | NCT04098653 | Allogeneic Hema... Conditioning Myeloid Tumors | Decitabine Busulfan (BU) Cyclophosphamid... | 14 Years - 65 Years | Nanfang Hospital, Southern Medical University | |
| Treatment of Myeloma in Patients <= 65 Years Old With Response >= 50% After HSC Autotransplant by Allogenic Transplant Genoidentical or Phenoidentical After Reduced Intensity Conditioning | NCT00466674 | Myeloma | reduced intensi... | 18 Years - 65 Years | Hospices Civils de Lyon | |
| IDA+BUCY vs BUCY Conditioning Regimen for Intermediate-risk AML Undergoing Auto-HSCT | NCT02671708 | Autologous Hema... Acute Myeloid L... Conditioning | Idarubicin（IDA） Busulfan (BU) Cyclophosphamid... | 14 Years - 65 Years | Nanfang Hospital, Southern Medical University | |
| G-CSF+DAC+BUCY vs G-CSF+DAC+BF Conditioning Regimen for Secondary Acute Myeloid Leukemia Undergoing Allo-HSCT | NCT05449899 | Secondary Acute... Allogeneic Hema... Conditioning | Granulocyte Col... Decitabine (DAC... Busulfan (BU) Fludarabine (FL... Cyclophosphamid... | 18 Years - 65 Years | Nanfang Hospital, Southern Medical University | |
| 10-day Decitabine, Fludarabine and 2 Gray TBI as Conditioning Strategy for Poor and Very Poor Risk AML in CR1 | NCT02252107 | Acute Myeloid L... | decitabine | 18 Years - | Radboud University Medical Center | |
| Pilot Trial of Clofarabine Added to Standard Busulfan and Fludarabine for Conditioning Prior to Allogeneic Hematopoietic Cell Transplantation | NCT01596699 | Myeloid Maligna... Bone Marrow Fai... Transfusion-dep... Congenital Immu... Metabolic Disea... Severe Immune D... | Alemtuzumab Busulfan Fludarabine Clofarabine | 3 Months - 30 Years | University of California, San Francisco | |
| Decitabine + BUCY vs BUCY Conditioning Regimen for TP53+ Myeloid Tumors Undergoing Allo-HSCT | NCT04123392 | TP53 Myeloid Tumors Conditioning Allogeneic Hema... | Decitabine Busulfan (BU) Cyclophosphamid... | 14 Years - 65 Years | Nanfang Hospital, Southern Medical University | |
| Efficacy and Safety of MTBF Conditioning Regimen for Salvageable Allo-HSCT in the Treatment of R/R AML | NCT06385808 | Relapse Leukemi... Refractory Acut... Conditioning Hematopoietic S... | MTBF regimen | 18 Years - 65 Years | First Affiliated Hospital Xi'an Jiaotong University | |
| Decitabine + BUCY vs BUCY Conditioning Regimen for TP53+ Myeloid Tumors Undergoing Allo-HSCT | NCT04123392 | TP53 Myeloid Tumors Conditioning Allogeneic Hema... | Decitabine Busulfan (BU) Cyclophosphamid... | 14 Years - 65 Years | Nanfang Hospital, Southern Medical University | |
| Modified BEAM Regimen for T Cell Lymphoma Underwent ASCT | NCT05814718 | Autologous Stem... Conditioning | modified BEAM BEAM | 18 Years - 60 Years | First Affiliated Hospital Xi'an Jiaotong University | |
| BUCYE Conditioning Regimen for PCNSL Undergoing Auto-HSCT | NCT03733327 | Primary Central... Autologous Hema... Conditioning | Busulfan (BU) Cyclophosphamid... Etoposide (VP-1... | 14 Years - 65 Years | Nanfang Hospital, Southern Medical University | |
| Dec+Flu+Bu Conditioning Regimen for Elderly AML in CR Undergoing Allo-HSCT | NCT03530085 | Acute Myeloid L... Allogeneic Hema... Conditioning Elderly | Decitabine Busulfan (BU) Fludarabine(Flu... | 60 Years - 80 Years | Nanfang Hospital, Southern Medical University | |
| Low Dose Decitabine + Modified BUCY Conditioning Regimen for High Risk Acute Myeloid Leukemia Undergoing Allo-HSCT | NCT03256071 | Acute Myeloid L... Allogeneic Hema... Conditioning | Decitabine plus... Modified BUCY | 12 Years - 60 Years | The First Affiliated Hospital of Soochow University |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
